Table 1.
Baseline Block | Block 1 | Block 2 | |
---|---|---|---|
P/S group (n = 10) | |||
CGI-I scale score (vs baseline)† | |||
1–2 | 0 | 0 | 9 |
3 | 3 | 2 | 1 |
4 | 5 | 6 | 0 |
5–6 | 2 | 2 | 0 |
Full response (>50%) | 0 | 0 | 7 |
Partial response (24%–49%) | 0 | 0 | 3 |
Remission (MADRS score ≤10) | 0 | 0 | 6 |
S/P group (n = 8) | |||
CGI-I scale score (vs baseline)† | |||
1–2 | 0 | 6 | 7 |
3 | 2 | 2 | 1 |
4 | 4 | 0 | 0 |
5–6 | 2 | 0 | 0 |
Full response (>50%) | 0 | 4 | 4 |
Partial response (25%–49%) | 0 | 2 | 4 |
Remission (MADRS score ≤10) | 0 | 3 | 4 |
Abbreviations: CGI-I, Clinical Global Impressions–Improvement; MADRS, Montgomery-Asberg Depression Rating Scale; P/S, placebo/scopolamine; S/P, scopolamine/placebo.
Data are given as number of patients.
In the CGI-I scale, 1 indicates very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; and 6, much worse.